HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
- 1 August 2000
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 47 (2) , 121-129
- https://doi.org/10.1016/s0166-3542(00)00102-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Disorders of the complement system in lipodystrophyPublished by Elsevier ,2004
- Inhibition of Adipocyte Differentiation by HIV Protease InhibitorsJournal of Clinical Endocrinology & Metabolism, 1999
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Therapeutic approaches to Type 2 diabetes mellitusExpert Opinion on Therapeutic Patents, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- NelfinavirDrugs, 1998
- StavudineDrugs, 1996
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.Journal of Clinical Investigation, 1993
- The Effect of Progesterone and of Insulin Administration on Regional Adipose Tissue Cellularity in the RatActa Physiologica Scandinavica, 1976